Blue Horseshoe Stocks: ECYT Recap & More

Endocyte, Inc. ECYT

We took notice of ECYT yesterday morning during our routine premarket scan, and due to some abnormal activity, we decided to include it in the daily watchlist.

It turned out to be a splendid idea, with the stock ultimately recording a hugely bullish session. ECYT traded from its low of 1.63 just following the open, to its high of 3.75 just prior to the close. It worked out to a single-session rip of 130% and it came on over 180X the monthly average volume. The stock has also hit a new high of 6.07 in the premarket this morning, pushing our observed move in less than 24 hours to a whopping 272%

It was especially impressive because of the timing, which couldn’t have been any better. Prior to yesterday’s session the stock was stagnating for several months. The move was catalyzed primarily by the announcement of the completion of a worldwide license on the company’s prostate cancer treatment, which will be moving on to Phase III development. (>>View PR)


Rigel Pharmaceuticals, Inc. RIGL

Speaking of solidly-timed calls on pharma plays, we also caught RIGL and included it in yesterday’s premarket report. It didn’t see the type of move that the previously mentioned stock, but got off to a respectable start.

RIGL traded in a range from 2.85-3.42, a modest rise of 20%, but did so on nearly 17X the monthly average volume, and closed near its high of day. We’ll continue to observe this play to see if it can establish a sustained uptrend.


Capricor Therapeutics, Inc. CAPR

We were just updating our readers yesterday morning on the moves CAPR had made since we had alerted it onSeptember 20th from its low of 1.80.

What followed was another nice session for the stock, which ran to a new high of 4.25; a total increase of 136% in a span of just eight trading days.



Tiffany & Co. TIF – Options Update

We also want to quickly update readers on our TIF options ideas that we submitted on the morning of September 28th, the TIF 10/20 $92-93 Calls. The stock has been in a continuous bullish pattern since then, and those calls made some pretty nice gains in the process.

$92 Calls – Range: 1.00-2.13 – Max Gain: 113%
$92.50 Calls – Range: .85-1.74  – Max Gain: 105%.
$93 Calls – Range: .83-1.88 – Max Gain: 127%


Extended Watchlist:
ETRM, VICL, DMPI, TA, KOOL, CATB

Blue Horseshoe Stocks: CAPR, VYGR, HMNY Recaps & More

Recent Big Winners

We have a large group of updates on previously called plays that we wanted to briefly swing back around and report performance information on this morning:

Voyager Therapeutics, Inc. VYGR – We alerted on VYGR on the 6th of September, witnessing a low of 12.33 and after finishing the rest of the month on a bullish streak, Friday brought a new high of 22.28. That’s a three week swing of 81%, which is fantastic for a stock in this price range.
______

Capricor Therapeutics, Inc. CAPR – We signaled our interest in CAPR later on in September,on the 20th. The following day we observed a low of 1.80, and like the above-mentioned play, it never looked back. Friday’s new high of 3.05, represented a 69% increase in just over a week’s time.
______

Helios and Matheson Analytics Inc. HMNY – We’ve discussed this one quite a bit recently, also beginning on September 20th. That morning  we saw a low of 5.469, and once again, it has been nothing but bullish moves ever since. On Friday the stock hit 14.17, marking a fantastic move of 159% in a little over a week.


Blackberry Ltd. BBRY – Options Recap

We also wanted to provide the final figures on the BBRY options we signaled in Thursday’s premarket report, the BBRY Weekly $9.50 & $10 Calls.  Friday’s session brought new highs for both sets.

The final intraweek range on the $9.50 Calls ended up being from .37 to 1.81 for a gain of 389%, while the $10′s breached the ten-bagger mark with an extraordinary run of 1025% from .12-1.35. Even readers who just caught Friday morning’s mention of these plays could still have made single-session profits of up to 103% and 202%, respectively.


Extended Watchlist:
SNCR, ECYT, MNKD, KTOV, ITUS, RIGL, SRAX, JAGX

Incoming search terms:

  • capr stock
  • hmny stock

Blue Horseshoe Stocks: MYO, HOS Reviews & More

Myomo, Inc. MYO

In terms of intraday gainers, MYO stole the show on Friday after appearing in our premarket report. Considering the fact that it was a ten dollar stock to begin with, the single-session rip we got from this play was fantastic.

From a low of 10.10 in the morning, MYO cruised its way to a high of 18.20 on over three times the monthly average volume. That worked out to an 80% move, and the stock closed with strength.

We’re going to be looking to MYO again as we kick off a new trading week today, as the stock has already bested Friday’s highs in premarket trading this morning. There may be a dip-and-rip formation, or a straight continuation of momentum, but either way we’ll want to see higher highs and higher lows established in order to confirm MYO as a multi-day runner and remain interested.


Hornbeck Offshore Services, Inc. HOS

Coming in as an honorable mention, also from Friday’s report, was HOS. The stock traded up from 2.26 and ran as high as 2.93. That logs as a intraday rise of 30%, and it traded six times its 30-day average volume.

Like the above-mentioned play, HOS had a pretty solid close, and is showing signs of potentially sustaining the trend it established leading into the end of last week.


Smart & Final Stores, Inc. SFS

Many grocery stocks took a hit at the end of last week amid the huge Amazon-Whole Foods deal, and there could definitely be rebound opportunities forthcoming as a result.

One such stock that caught our eye is SFS, which was hammered down to new 52-week lows on Friday. Purely from a technical standpoint we’d be interested in this for potential bottom plays in the stock and the options chain as well. We’ll signal the SFS 08/18 $10 Calls for observation over an extended term.


Extended Watchlist:
RIGL, RWLK, WKHS, BVXV, BSTG, MSDI, ORIG

Blue Horseshoe Stocks: RUSS & More

Direxion Daily Russia Bear 3X ETF (RUSS)

By now we all have at least a limited awareness of the conflict currently underway in the Balkans, but just in case, let us provide a brief synopsis.

Ukrainian forces in the country’s eastern region have been clashing with militant separatists, even despite a recent cease-fire agreement. The separatists desire a return to Russian rule, and it appears that the group’s efforts have been aided by the Russian government.  As a result, heavy economic sanctions have already been placed on Russia, and it has been said that more are being explored.

The RUSS ETF trades with an inverse relationship to the Russian economy, so it’s conceivable that while Russia struggles with the economic repercussions of the conflict in the Ukraine, we could potentially see a protracted rise in this fund.

As you can see on the snapshot below, already it is showing indications of a reversal on the chart, exhibiting many of the characteristics of a prime bottom-play. As we kick off a new trading week, RUSS will be one of our primary items of interest.



Notable Mention From Friday

If you recall, we included a side note at the end of Friday’s report wherein we ventured that a market reversal and downturn could lead us to some interesting opportunities $22 UVXY Calls. While the markets overall continued their upward momentum, those traders who were quick on the draw could still have made a substantial profit from those contracts before they saw a pullback.

The $22 Calls made a strong initial push right out of the gate, running rapidly from 36-.63, a 75% intraday spike.

As you can see from the snapshot of the actual trade data of one of our top traders, significant profits were there for the taking early, even if one didn’t catch the low. From an initial block of $1860, he was able to cash out at the high of day for a 34% return in less than a half hour, leaving him with nearly $2500!


Extended Watchlist:
RIGL, BLDP, GEVO, BIOC, OCN